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Abstract
Introduction Mechanisms underlying inotropic failure in septic
shock are incompletely understood. We previously identified the
presence of exosomes in the plasma of septic shock patients.
These exosomes are released mainly by platelets, produce
superoxide, and induce apoptosis in vascular cells by a redox-
dependent pathway. We hypothesized that circulating platelet-
derived exosomes could contribute to inotropic dysfunction of
sepsis.
Methods We collected blood samples from 55 patients with
septic shock and 12 healthy volunteers for exosome separation.
Exosomes from septic patients and healthy individuals were
investigated concerning their myocardial depressant effect in
isolated heart and papillary muscle preparations.
Results Exosomes from the plasma of septic patients
significantly decreased positive and negative derivatives of left
ventricular pressure in isolated rabbit hearts or developed
tension and its first positive derivative in papillary muscles.
Exosomes from healthy individuals decreased these variables
non-significantly. In hearts from rabbits previously exposed to
endotoxin, septic exosomes decreased positive and negative
derivatives of ventricular pressure. This negative inotropic effect
was fully reversible upon withdrawal of exosomes. Nitric oxide
(NO) production from exosomes derived from septic shock
patients was demonstrated by fluorescence. Also, there was an
increase in myocardial nitrate content after exposure to septic
exosomes.
Conclusion Circulating platelet-derived exosomes from septic
patients induced myocardial dysfunction in isolated heart and
papillary muscle preparations, a phenomenon enhanced by
previous in vivo exposure to lipopolysaccharide. The generation
of NO by septic exosomes and the increased myocardial nitrate
content after incubation with exosomes from septic patients
suggest an NO-dependent mechanism that may contribute to
myocardial dysfunction of sepsis.Page 1 of 10
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DAF = 4,5-diaminofluorescein; +dP/dtmax = maximal positive derivative of left ventricular pressure; -dP/dtmax = maximal negative derivative of left ven-
tricular pressure; DT = developed tension; +dT/dt = positive temporal derivative of developed tension; EDTA = ethylenediaminetetraacetic acid; IL = 
interleukin; L-NAME = N(G)-nitro-L-arginine methyl ester; LPS = lipopolysaccharide; NO = nitric oxide; NOS = nitric oxide synthase; NOS2 = induc-
ible nitric oxide synthase; PMSF = phenylmethylsulfonyl fluoride; ROS = reactive oxygen species; RT = resting tension; SOD = superoxide dismutase; 
TNF-α = tumor necrosis factor-alpha.
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Septic shock remains one of the most challenging medical
conditions, with increasing incidence over the last years. The
tendency of such an increase is probably due to progressive
aging of the population, improvements in critical care support,
and progress in chemotherapy and immunosuppressive thera-
pies, with increased life expectancy of immunosupressed
patients and patients with malignancies. Although much has
been learned about the pathophysiology of sepsis in the last
decade, the mortality of this condition is still elevated.
One of the most important features of sepsis is myocardial
dysfunction [1-3]. Studies with echocardiogram and radionu-
clides show biventricular dilatation and decrease in ejection
fraction in septic patients [3]. This myocardial depression is
reversible in most individuals after 7 to 10 days, and the exact
correlation of this dysfunction with the prognosis is incom-
pletely understood [4].
Several hypotheses have been formulated to explain the
decrease in myocardial function in sepsis. Cytokines such as
interleukin (IL)-1 and tumor necrosis factor-alpha (TNF-α) [5]
and, more recently, reactive oxygen/nitrogen species (nitric
oxide [NO], superoxide, and peroxynitrite) have been impli-
cated in the mechanism [6-8], with studies showing a
decrease in myocardial contractility after exposure to such
intermediates. However, the search for a specific protein char-
acterized as 'sepsis myocardial depressant factor' continues,
with controversial results.
A previous report from our laboratory showed the presence in
the plasma of septic patients of microparticles characterized
as exosomes [9]. These particles were characterized to be
predominantly derived from platelets. Microparticles are vesic-
ular or lamellar structures released by several cell lines after
activation or apoptosis, which have been related to vascular
dysfunction and activation of coagulation in sepsis [10,11].
Exosomes are a particular type of microparticles produced by
the endocytic-lysosomal system of several cell lines after acti-
vation [12]. Platelet-derived exosomes are lamellar particles
with diameters of approximately 100 nm with few procoagu-
lant properties which do not bind annexin V. The presence of
tetraspan proteins (such as CD37 and CD63) in exosome
membrane suggests that they may have signaling and adhe-
sion purposes, although the exact function of these particles
needs to be determined [9,13]. The previous study showed
that exosomes derived from septic shock patients possess
NAD(P)H oxidase activity identified by lucigenin-induced
chemiluminescence and cytochrome c reduction assay and
exhibit a potent proapoptotic effect in endothelial and smooth
muscle vascular cells through a redox-dependent pathway [9].
Since redox mechanisms may be involved in cardiovascular
dysfunction of sepsis [14], we conducted this study in order
to evaluate a possible role for platelet-derived exosomes in
sepsis-related myocardial dysfunction and possible redox
mechanisms underlying such effects.
Materials and methods
All chemicals and reagents were purchased from Sigma-
Aldrich (St. Louis, MO, USA) unless otherwise specified.
Preparation of exosomes
We collected blood samples (50 mL) of 55 patients from the
Emergency Medicine Intensive Care Unit of Hospital das Clin-
icas, University of São Paulo, Brazil, with early (less than 48
hours) diagnosis of septic shock defined according to the cri-
teria of the American College of Chest Physicians and the
Society of Critical Care Medicine [15]. Twelve healthy volun-
teers from our laboratory provided blood samples that served
as controls. The study was approved by the institutional ethics
and review board, and informed consent was obtained from
the patient's next of kin. Animal care and handling of animals in
the study were in accordance with guidelines of the National
Institutes of Health (Bethesda, MD, USA).
The technique for isolating exosomes was performed as
described previously [9]. Briefly, blood was collected in centri-
fuge tubes containing 5 U/mL heparin, and all procedures
were carried out at 4°C. Cells, platelets, and large debris were
pelleted by centrifugation at 3,000 g for 10 minutes. Three
(3.0) mM phenylmethylsulfonyl fluoride (PMSF), 1 μg/mL apro-
tinin, and pepstatin were added to the supernatant, which then
was sequentially filtered through 1-, 0.45-, and 0.22-μm nylon
filters to remove platelets, cellular fragments, and apoptotic
bodies. The remaining cell-free plasma was ultracentrifuged at
140,000 g for 150 minutes. The pellet containing exosomes
first was washed with Tris (50 mM)-buffered saline (NaCl 150
mM) with ethylenediaminetetraacetic acid (EDTA) (0.1 mM) to
avoid contamination with plasma proteins and then was resus-
pended with the same buffer. Protein concentration was
measured by the Bradford method (Bio-Rad Laboratories
GmbH, München, Germany). After separation procedures,
healthy individuals generated samples with 5.8 ± 0.96 mg of
exosome protein per milliliter of solution, whereas septic
patients generated samples with 16.5 ± 0.99 mg of exosome
protein per milliliter of solution (P < 0.05, t test).
Electron microscopy
In experiments involving electron microscopy, exosome sepa-
ration was performed without the steps of filtration and ultra-
centrifugation, in order to avoid aggregation of exosomes.
Briefly, the plasma of septic patients was centrifuged at
11,000 g for 2 minutes to obtain platelet-poor plasma. A buffer
containing Tris-NaCl-EDTA and PMSF 3 mmol/L was added
to plasma, and another centrifugation (13,000 g for 90 min-
utes) was performed. The pellet was then resuspended in 100
μL of the same buffer. Under FORMVAR® grids (Structure
Probe, Inc West Chester, PA, USA), 10 μL of exosome sam-
ples was deposited for 30 seconds for film absorption. There-Page 2 of 10
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grids, and these samples were submitted to transmission elec-
tron microscopy in a Philips EM-420 microscope (Philips,
Eindhoven, The Netherlands).
Isolated heart preparation
Fifty male New Zealand rabbits weighing 2.5 to 3.5 kg were
anesthetized with chloralose (60 mg/kg) and urethane (600
mg/kg) and were heparinized (250 IU). We performed a tra-
cheotomy and submitted the rabbits to mechanical ventilation
throughout the entire procedure. A torachotomy was per-
formed, and the aorta was cannulated and perfused at a con-
stant flow of 15 mL/minute with Krebs-Henseleit solution
(composition NaCl 115 mM, KCl 5.4 mM, CaCl2 1.25 mM,
NaHCO3 25 mM, MgSO4 1.2 mM, NaH2PO4 1.15 mM, and
glucose 11 nM) at pH 7.40 equilibrated with 95% O2/5%
CO2 and at a constant temperature of 37°C, in order to main-
tain the heart with a retrograde coronary perfusion, according
to the Langendorff technique. The heart was excised, an inci-
sion was made in the left atrium, and a ventricular drain as well
as a fluid-filled latex balloon were inserted through the mitral
orifice into the left ventricle. The balloon was filled to achieve
a constant diastolic pressure of 5 mm Hg. We recorded left
ventricular pressure, and the maximal positive (+dP/dtmax) and
negative (-dP/dtmax) left ventricular pressure derivatives were
electronically derived from the left ventricular signal by means
of a data acquisition system (Biopac MP100; Biopac Sys-
tems, Inc., Goleta, CA, USA). Hearts were maintained at 37°C
throughout the experiment by enclosing the heart in a temper-
ature-regulated double-glass chamber.
After a 15-minute stabilization period, we started the infusion
of exosomes in a closed recirculating system (total volume of
100 mL) to achieve a concentration equal to one half of
plasma concentration. This concentration was chosen after
preliminary experiments depicted similar effects of exosome
infusion in concentrations varying from 0.5 to 1× plasma con-
centrations. The system was maintained under perfusion for
20 minutes. After this period, the system was again perfused
for 15 minutes with Krebs-Henseleit solution free of exo-
somes. In another set of experiments, the system was per-
fused 20 minutes before and during exosomes infusion with
specific reactive oxygen species (ROS) inhibitors (Table 1) in
order to confirm or disclose involvement of different ROS gen-
eration pathways.
To investigate the effects of exosome infusion in an experimen-
tal model more closely related to human septic shock, rabbits
were challenged with endotoxin (lipopolysaccharide [LPS]
Escherichia coli serotype 026:B6) in a concentration of 1 mg/
kg 6 hours before sacrifice. Three hours after exposure, rabbits
were resuscitated with 8 mL/kg saline to reduce hypovolemia,
which is a hallmark of this model. After 6 hours of LPS expo-
sure, the hearts were removed and the experiments were per-
formed as already described.
Isolated papillary muscle preparations
Ten Wistar male rats weighing 350 to 450 g were anesthe-
tized with ketamine and xylazine (0.1 mL per 100 mg of body
weight each). A torachotomy was performed, and the heart
was excised and immediately immersed in oxygenated (95%
O2 and 5% CO2) Krebs-Henseleit solution (composition NaCl
118.5 mM, KCl 4.69 mM, CaCl2 2.52 mM, NaHCO3 25.88
mM, MgSO4 1.16 mM, KH2PO4 1.18 mM, and glucose 5.50
mM) in a bath at 29°C. The left ventricular chamber was
opened, and anterior and posterior papillary muscles were dis-
sected. Two stainless steel rings held the extremities of the
muscles, and the muscles were vertically mounted in an organ
bath filled with 35 mL of the same Krebs-Henseleit solution.
The upper extremity of the muscle was connected by the ring
to a force transducer (Grass FT 03 model; Grass Technolo-
gies, West Warwick, RI USA), and the inferior ring was con-
nected to a micromanipulator (Mitutoyo model 2046F;
Mitutoyo Corporation, Aurora, IL, USA). The muscles were
stimulated electrically at 0.2 Hz and at a voltage approximately
10% above threshold by rectangular pulses of 5-millisecond
duration through two longitudinally placed platinum elec-
trodes. The preparation was stabilized for 30 minutes at the
muscle length at which the maximal active tension was devel-
oped. After stabilization, exosomes from septic patients and
healthy volunteers in a concentration equal to one half of
plasma concentration were incubated in bathing solution and
maintained for 45 minutes. The parameters recorded were
developed tension (DT), resting tension (RT), positive tempo-
Table 1
Targeted reactive oxygen species generation pathways
Inhibitor (final concentration) Pathway inhibited
Diphenylene iodonium (0.02 mM) Flavoenzymes, in particular NADPH oxidase
Indomethacin (0.1 mM) Cyclooxygenase
Apocynin (1 mM) NADPH oxidase
N-acetyl cysteine (3 mM) Anti-oxidant; thiol group donor
L-monomethyl-arginine (0.1 mM) Nitric oxide synthasePage 3 of 10
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poral derivative of developed tension (-dT/dt). These two
derivatives report temporal variations in contraction and relax-
ation myocardial capabilities, respectively.
Organ chamber experiments
Rat thoracic aortas from 10 Wistar rats were carefully dis-
sected and divided in four 5-mm-long rings that were sus-
pended in two intraluminal parallel wires, introduced in an
organ bath containing Krebs-Hepes at a constant temperature
of 37°C, and equilibrated with 95% O2/5% CO2. An initial iso-
metric contraction period with a DT of 2 g for 60 minutes was
performed. During this period, two segments were incubated
for 2 hours with exosomes from septic patients and from
healthy volunteers in a concentration equal to plasma concen-
tration. Immediately before the phase of preconstriction, a third
ring was incubated with the same concentration of exosomes
from septic patients. All the vessels were precontracted with
norepinephrine 10-7 M, and vascular tension was registered
every 2 minutes. After a period of 15 minutes for equilibrium,
concentration response curves to acetylcholine (10-9 to 3 ×
10-5 M) were performed. In other experiments, vascular rings
were incubated with exosomes overnight and analyzed the
next day as described above.
4,5-Diaminofluorescein-derived fluorescence in 
exosomes
Recently, observations from the laboratory of one of the
authors (MJ) demonstrated the presence of inducible NO syn-
thase (NOS) in exosomes from septic shock patients [16].
Thus, we carried out these experiments in order to assess NO
production from septic exosomes by using the fluorescent
probe 4,5-diaminofluorescein (DAF)-2 (Calbiochem, now part
of EMD Biosciences, Inc., San Diego, CA, USA). This method
is based on the reaction of DAF-2 with NO in the presence of
O2 under neutral pH, yielding the highly fluorescent DAF-2T.
DAF-2 (5 μM) was added to a suspension containing 10 μg of
exosome protein in 100 μL of Krebs buffer (pH 7.4). After a
stabilization period of 5 minutes, fluorescence measurements
were acquired at 37°C in an Amersham FARCyte/Tecan Ultra
fluorescence plate reader (Amersham Biotech, now part of GE
Healthcare, Little Chalfont, Buckinghamshire, UK). Excitation
wavelength was set to 495 nm, emission was set to 520 nm,
and measurements corresponding to 40-microsecond integra-
tion of signals were obtained by 10 flashes. In some experi-
ments when indicated, N(G)-nitro-L-arginine methyl ester (L-
NAME) (100 μM) or superoxide dismutase (SOD) (250 IU/
mL) was added to the exosomes 20 minutes before DAF-2.
Autofluorescence was corrected for by the inclusion of parallel
blanks and did not exceed 10% of the total fluorescence. Data
are expressed as arbitrary fluorescence units per milligram of
exosome protein.
Nitrate content in septic exosomes and in myocardial 
tissue
Samples of exosomes from septic patients were separated
from their protein content by diluting the samples in an equal
volume of trichloroacetic acid (10%) followed by centrifuga-
tion at 10,000 rpm for 10 minutes. Their intrinsic nitrate con-
tent was measured by chemiluminescence in a Sievers
analyzer (model 280; Sievers Instruments, Inc., Boulder, CO,
USA) with VCl3 and HCl (at 95°C) as reductants. Results were
normalized for protein concentration.
In other experiments, isolated rabbit heart preparations were
exposed for 45 minutes to exosomes of septic patients and
healthy volunteers. After exposure, the system was perfused
for 5 minutes with Krebs-Henseleit solution at 4°C free of exo-
somes. The heart was removed, and myocardial tissue was
carefully dissected and immersed in liquid nitrogen. The hearts
were minced under liquid nitrogen, and the homogenate was
resuspended in 1 mL of Tris HCl buffer (50 mM, pH 7.40) con-
taining mercaptoethanol (0.1%) and PMSF (1 mM) and centri-
fuged at 5,000 g for 5 minutes at 4°C. The supernatant was
collected, and protein was quantified by the Bradford method.
Samples (20 μL) had their nitrate content measured as
described before, and the results were normalized for myocar-
dial protein concentration.
Statistical analysis
Data were considered normal using the Kolmogorov-Smirnov
goodness-of-fit model and are presented as mean ± standard
error of the mean. Single means were compared with the Stu-
dent t test and paired t test as indicated, and a p value of less
than 0.05 was considered significant. Means within group and
between groups as well as the factor × time interaction were
analyzed using two-way analysis of variance (analysis of vari-
ance two-way) with Bonferroni's correction for multiple com-
parisons. Post hoc analysis was performed with the Tukey
test. The software used was Sigma Stat 2.0 software (Systat
Software, Inc., San Jose, CA, USA).
Results
Electron micrograph of exosomes
Figure 1 depicts transmission electron micrography of exo-
somes from septic patients. Exosomes were identified as
round particles with diameters ranging from 50 to 150 nm,
consistent with previous reports [13], with no deposit of elec-
tron-dense material (negative stain). Some larger particles can
also be seen in the preparation, probably corresponding to
microparticles derived from plasma membranes.
Baseline heart function data
Table 2 depicts baseline data from isolated heart and isolated
papillary muscle preparations. There were no significant differ-
ences in these parameters before infusion of exosomes from
septic patients or healthy volunteers.Page 4 of 10
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Figure 2a,b depicts the effects of exosome infusion on positive
and negative dP/dtmax in isolated heart preparations. Incuba-
tion of the recirculating system with exosomes derived from
septic patients at 0.5× plasma concentration induced a statis-
tically significant decrease in myocardial contractility assessed
through both positive and negative derivatives of left ventricu-
lar pressure when compared with baseline. This effect, how-
ever, was not statistically significant when compared with
control exosomes. After 20 minutes, the exosome preparation
was removed from the system and there was a spontaneous
return of myocardial function to baseline levels after 15 min-
utes, indicating that the effects are reversible. Incubation with
exosomes obtained from healthy individuals induced a non-
significant decrease in myocardial contractility (p values at 20
minutes were 0.536 for +dP/dtmax and 0.306 for -dP/dtmax).
Effects of reactive oxygen species inhibitors in exosome-
induced myocardial dysfunction
To identify the mechanisms inducing exosome-dependent
myocardial dysfunction, we performed experiments in which
the perfusate was preincubated for 20 minutes with ROS
inhibitors or redox-active compounds (Table 1) before exo-
some exposure. Overall, the reduction in positive and negative
derivatives of ventricular pressure induced by exosomes and
demonstrated in Figure 2 was largely not affected by the inhib-
itors tested (Figure 3a,b). Of note, however, the NAD(P)H oxi-
dase antagonist apocynin induced a larger and statistically
significant decrease in positive dP/dtmax, an effect not depend-
ent on a direct action of the inhibitor on myocardial perform-
ance, since preincubation of the heart with apocynin before
exosome exposure did not induce myocardial dysfunction
(data not shown). We postulated that this effect could be
mediated by increased availability of NO, due to apocynin-
mediated decrease in superoxide production. Nevertheless,
an apparent obstacle to this proposal was that NOS inhibition
did not correct the loss in myocardial contractility. This result,
however, should be taken with caution since NOS inhibition
can promote significant vasoconstriction and lead to myocar-
dial dysfunction [17].
Effect of exosome infusion in endotoxemic hearts
Hearts from endotoxemic rabbits were exposed to exosomes
from septic individuals (Figure 4a,b). The mean baseline values
obtained for positive and negative derivatives of ventricular
pressure from endotoxemic hearts were, on average, 35% less
than the values obtained from previously normal hearts (endo-
toxemic rabbits: +dP/dtmax, 1,743.4 ± 266 mm Hg/s; -dP/
dtmax, 1,225.1 ± 231 mm Hg/s). Despite the baseline dysfunc-
Table 2
Baseline data from isolated heart and isolated papillary muscle preparations
Isolated heart Isolated papillary muscle
Parameters Heart rate 
(bpm)
+dP/dtmax
(mm Hg/s)
-dP/dtmax
(mm Hg/s)
DTmax (g) Resting tension 
(g)
+dT/dt (g/s) -dT/dt (g/s)
Septic exosomes 123 ± 4 3,676 ± 366 2,925 ± 336 5.3 ± 0.4 0.75 ± 0.07 52.6 ± 5.5 22 ± 3
Control exosomes 128 ± 3 3,136 ± 340 2,321 ± 469 5.7 ± 0.4 0.74 ± 0.1 63.8 ± 4.5 32.7 ± 2
P value 0.562 0.352 0.286 0.545 0.936 0.218 0.05
Data for isolated heart preparations are from nine experiments for septic exosomes and five experiments for control exosomes; data for isolated 
papillary muscle preparations are from eight experiments for septic exosomes and four experiments for control exosomes. +dP/dtmax, maximal 
positive derivative of left ventricular pressure; -dP/dtmax, maximal negative derivative of left ventricular pressure; DTmax, maximal developed tension 
of isolated papillary muscle; +dT/dt, positive temporal derivative of developed tension; -dT/dt, negative temporal derivative of developed tension.
Figure 1
Exosomes from patients with septic shock. Electron micrograph of exo-
somes isolated from the plasma of patients with sepsis, showing round 
particles with diameters ranging from 50 to 150 nm. Magnification, × 
41,000.Page 5 of 10
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endotoxemic hearts induced a significant decrease in contrac-
tility when compared with baseline and, in addition, a signifi-
cant decrease in +dP/dtmax as compared with infusion of
septic and healthy exosomes in normal hearts not previously
exposed to LPS. These results indicate that, in myocardial tis-
sue primed by prior LPS exposure, exosomes may induce a
more important negative inotropic effect.
Isolated papillary muscle preparations
Although isolated heart preparations are well-established sys-
tems for measuring myocardial performance, they may be sub-
ject to several pitfalls. To expand our results with isolated
hearts, we incubated isolated rat papillary muscle preparations
for 45 minutes with exosomes from septic patients and healthy
volunteers at 0.5× plasma concentration. Exosomes from sep-
tic patients induced a statistically significant decrease in max-
imal DT and +dT/dt (Figure 5a,b), whereas exosomes from
control individuals did not induce a decrease in these varia-
bles. Exosomes from septic patients or healthy volunteers did
not induce a decrease in RT nor in its rate of temporal variation
(data not shown). These results show a consistent inhibitory
effect of the preparation of exosomes in myocardial function.
Effect of exosomes in vascular reactivity
Standard curves of norepinephrine-mediated contraction and
acetylcholine-mediated relaxation did not depict a significant
direct effect of exosomes in vascular tone (data not shown).
These data were assessed with concentration of exosomes
equal to plasma concentrations and different periods of incu-
bation (2 hours and overnight incubation).
Nitric oxide production by exosomes and nitrate content 
in myocardium
Figure 6a depicts NO production assessed by DAF fluores-
cence from samples of exosomes from septic patients and
healthy subjects. Exosomes from septic patients induced sig-
nificantly increased production of NO when compared with
those from healthy volunteers. Specificity of DAF assay was
confirmed by the inhibitory effects of L-NAME and by the
absence of effects of SOD.
Exosomes from septic shock patients had an intrinsic nitrate
content of 0.026 ± 8.5 μM per microgram of exosome protein.
The nitrate myocardium content of hearts incubated for 45
minutes with normal and septic exosomes is demonstrated in
Figure 6b. As shown, septic exosomes induced a significant
increase in myocardial nitrate content. Taken together, these
results indicate an intrinsic production of NO by exosomes as
well as an increase in the myocardial NO pool induced by exo-
somes from septic individuals. This activation may be linked to
myocardial dysfunction.
Discussion
In this study, we showed for the first time that (patho)physio-
logically relevant concentrations of platelet-derived exosomes
from septic patients induce a decrease in myocardial contrac-
tility in isolated heart and papillary muscle preparations. The
effect of exosomes is enhanced by previous exposure to LPS.
Therefore, exosomes may be implicated in myocardial dys-
function of sepsis. Exosomes also contain NOS, generate NO,
and induce myocardial NO production. These data provide evi-
dence that NO may be a pathway for septic exosome-derived
myocardial dysfunction.
In our Langendorff model, exosomes induced a significant
decrease in myocardial contractility assessed by positive
derivative of ventricular pressure. However, in these prepara-
tions, myocardial contractility is dependent on several varia-
bles, such as coronary perfusion pressure and heart rate, and
compounds affecting these indices may not have an intrinsic
myocardial depressant effect. Thus, we decided to perform
some experiments in a system in which the effect of exosomes
in myocardial contractility could be measured. The experi-
ments with isolated papillary muscles demonstrated unequivo-
cally an inhibitory effect of exosomes in myocardial function.
However, in isolated papillary muscles, exosomes decreased
myocardial performance only in the DT and its positive tempo-
ral derivative. This finding may be due to the possible depend-
ence of myocardial relaxation on some peculiarities of the
isolated heart, such as changes in transmural perfusion. The
lack of a direct effect of exosomes in vascular tone evidenced
in this study argues against a direct effect of exosomes in cor-
onary tone. This result also contrasts with the decreased relax-
ation verified after exposure of vessels to other types of
microparticles, such as vesicular particles exposing phos-
phatydilserine [10].
In LPS-treated rabbits, exosomes induced more significant
decreases in myocardial function. It is noteworthy that these
preparations had baseline levels of dP/dt, on average, 65%
lower than normal hearts. The enhanced effect of exosomes in
myocardial contractility of septic hearts may be partially
explained by the results obtained by Clayton and colleagues
[18] which suggest that, in systems previously activated by
inflammatory mediators, exosomes may have their effect
enhanced due to their increased adherence to target cells pro-
moted by adhesion molecule exposure.
Although the experiments with inhibitors could not clarify the
precise mechanism of myocardial dysfunction, they were
important for ruling out several possible pathways. In particu-
lar, experiments with apocynin, a specific NADPH oxidase
inhibitor, called our attention to the possibility of NO-mediated
dysfunction. Our results with L-monomethyl-arginine do not
rule out NO as the mediator of myocardial dysfunction, proba-
bly due to coronary vasoconstriction induced by NO antago-
nism [17].Page 6 of 10
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cardial dysfunction. Classic studies have linked cytokine pro-
duction to cardiac dysfunction mediated by myocardial NOS
[19,20]. One study reported that, immediately after incubation
of isolated papillary muscles with cytokines such as TNF-α and
IL-6, there was a concentration-dependent and reversible inhi-
bition of myocardial contractility [19], an effect very similar to
our results. In that study, incubation with NO inhibitors
blocked the depression, but removal of endocardial endothe-
lium did not alter the response. The authors suggest that the
enzyme probably involved in this dysfunction is constitutive
NOS (NOS3) since the rapid onset of the effect did not sug-
gest a mechanism requiring gene transcription [19].
Inducible NOS (NOS2) has also been linked to myocardial
dysfunction of sepsis [21-23]. Mice lacking NOS2 are pro-
tected against endotoxin-induced myocardial depression, and
inhibition of this enzyme with specific compounds prevents
this effect [22]. Since our exosomes carry NOS2 and their
incubation promoted increased myocardial content of NO, it is
also possible that the presence of this enzyme may stimulate
myocardial production of NO, thus contributing to our results.
Another possible source of myocardial depression is peroxyni-
trite and/or related toxic by-products of reaction between NO
and superoxide. Ferdinandy and colleagues [7] demonstrated
that infusion of cytokines such as TNF-α or IL-1-β is associ-
ated with impairment of cardiac mechanical function in iso-
lated hearts, accompanied by increased myocardial activities
of NOS2, xanthine oxidoreductase, and NADH oxidase. The
levels of nitrotyrosine and dityrosine (markers of peroxynitrite
formation) were enhanced in the perfusate, whereas treatment
with ROS scavengers such as tiron and NOS inhibitors
blocked myocardial dysfunction [7]. The authors concluded
that ROS (particularly peroxynitrite) were involved in cytokine-
Figure 2
Effect of exosomes on left ventricular pressure in isolated rabbit heart preparations
preparations. Time course of positive (a) and negative (b) derivatives of 
left ventricular pressure after infusion of exosomes from septic patients 
and healthy volunteers. Data are mean ± standard error of the mean of 
nine experiments for exosomes derived from septic patients and five 
experiments for exosomes from healthy individuals. *p < 0.05 versus 
baseline; #p < 0.05 versus 20 minutes (analysis of variance two-way, 
Tukey test). +dP/dtmax, maximal positive derivative of left ventricular 
pressure; -dP/dtmax, maximal negative derivative of left ventricular pres-
sure.
Figure 3
Effect of reactive oxygen species (ROS) inhibitors on exosome-induced inhibi i n of left ventricular pres ure
inhibition of left ventricular pressure. Effect of ROS inhibitors on exo-
some-induced inhibition of maximal positive (a) and negative (b) deriva-
tives of ventricular pressure. Data are mean ± standard error of the 
mean of nine experiments for exosomes from septic patients, four 
experiments for septic exosomes + L-monomethyl-arginine (LNMMA), 
five experiments for septic exosomes + n-acetylcysteine (NAC), four 
experiments for septic exosomes + dyphenyleneiodonium (DPI), three 
experiments for septic exosomes + apocynin (APO), and three experi-
ments for septic exosomes + indomethacin (INDO). *p < 0.05 versus 
septic; (analysis of variance two-way, Tukey test). +dP/dtmax, maximal 
positive derivative of left ventricular pressure; -dP/dtmax, maximal nega-
tive derivative of left ventricular pressure.Page 7 of 10
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a good candidate to underlie our effects since treatment of the
hearts with ROS inhibitors did not reverse the inhibitory effect
of exosomes.
Although our results are encouraging, some study limitations
should be considered. First, the isolated heart or papillary mus-
cle preparations provide interaction of exosomes with different
cell types. Thus, our results should not be taken to represent
exclusively the effects of exosomes with cardiomyocytes. Par-
ticularly, in isolated hearts, effects of exosomes on coronary
vascular tone could account for the observed dysfunction, a
limitation overcome in the papillary muscle preparation and
also discouraged by the absence of an effect of exosomes on
isolated vessels. On the other hand, taken together, the
strength and reproducibility of the effects in both preparations
suggest at least some direct effect of exosomes on myocardial
contractility. A puzzling question was the observed effect of
healthy exosomes in the myocardium. Although this effect was
small and not statistically significant versus baseline, it was
sufficiently evident to jeopardize a statistical difference with
septic exosomes. Indeed, there is evidence in the literature of
a cellular effect of 'sham' exosomes, mainly related to ROS
production [9,24]. Thus, it is apparent that the observed effect
of septic plasma exosomes may be due both to an increased
number of exosomes as well as an intrinsic property of such
particles. Since a reliable method of exosomes quantitation in
plasma is not available, this issue remains open. In any case,
however, our data clearly show that myocardial effects of exo-
somes make a potentially important contribution to septic myo-
cardial dysfunction.
Conclusion
This study showed that (patho)physiologically relevant con-
centrations of exosomes derived from platelets of patients with
septic shock may induce myocardial dysfunction in isolated
rabbit hearts and isolated papillary muscle preparations. The
increase in myocardial dysfunction after LPS exposure and the
increase in myocardial content of NO derivatives as well as the
production of NO by exosomes from septic patients suggest
that NO may be a significant contributor to this phenomenon.
Although the significance of this dysfunction in vivo is not yet
established, the data depicted here indicate that exosomes
present in the circulation may represent a novel redox-signal-
Figure 4
Amplification of the effects of exosomes on left ventricular contractility upon prev us exposur  to lipop lysaccharide (LPS)
upon previous exposure to lipopolysaccharide (LPS). Effect of exo-
somes on percentage of maximal positive (a) and negative (b) deriva-
tives of left ventricular pressure in endotoxemic hearts. Data are mean 
± standard error of the mean of experiments with exosomes from septic 
patients on normal hearts (septic ex, n = 9), exosomes from healthy 
individuals on normal hearts (healthy ex, n = 5), and exosomes from 
septic patients in endotoxemic hearts (septic ex + LPS, n = 4). *p < 
0.05 versus baseline; #p < 0.05 versus septic ex; §p < 0.05 versus 
healthy ex (analysis of variance two-way, Tukey test). +dP/dtmax, maxi-
mal positive derivative of left ventricular pressure; -dP/dtmax, maximal 
negative derivative of left ventricular pressure.
Figure 5
Effect of exosomes in isolated rat papillary muscle preparations. Effect 
of exosomes on developed tension (a) and its positive derivative (+dT/
dt) (b) in isolated rat papillary muscle preparations. Data are mean ± 
standard error of the mean of eight experiments for papillary muscles 
before and after incubation with exosomes derived from septic patients 
(septic pre and post) and four experiments for papillary muscles before 
and after incubation with exosomes derived from healthy individuals 
(healthy pre and post). *p < 0.05 versus septic pre (paired t test).Page 8 of 10
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